Louise Chen

Stock Analyst at Scotiabank

(1.14)
# 1953
Out of 5,356 analysts
345
Total ratings
43.16%
Success rate
2.83%
Average return
68 Stocks
Name Action PT Current % Upside Ratings Updated
BPMC Blueprint Medicines
Downgrades: Sector Perform
135
127.86 5.58% 2 Jun 2, 2025
ACRS Aclaris Therapeutics
Maintains: Sector Outperform
15 9
1.55 480.65% 6 May 9, 2025
EWTX Edgewise Therapeutic...
Downgrades: Sector Perform
50 14
14.78 -5.28% 2 Apr 3, 2025
SRPT Sarepta Therapeutics
Maintains: Sector Perform
105 80
39.13 104.45% 2 Mar 20, 2025
GANX Gain Therapeutics
Initiates Coverage On: Sector Outperform
12
1.89 534.92% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
55
21.16 159.92% 5 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Perform
55
51.76 6.26% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
15
3.15 376.19% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
50
23.57 112.13% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
15
3.65 310.96% 5 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
17
5.99 183.81% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
70
35.69 96.13% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
50
13.97 257.91% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
30
13.46 122.88% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
55
36.46 50.85% 8 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
160 160
72.5 120.69% 20 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 6 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
45 45
23.1 94.81% 31 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
215 215
153.51 40.06% 40 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
155 155
77.59 99.77% 25 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 9 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
885 885
764.43 15.77% 45 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 10 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 6 Aug 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 6 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
200 200
187.31 6.77% 5 Aug 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 2 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 2 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 2 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
925 925
482.56 91.69% 1 Apr 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
2.78 2238.13% 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
25
n/a n/a 4 Oct 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5
0.78 541.03% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
25
2.28 996.49% 4 Sep 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
50
15.28 227.23% 3 Sep 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
20
n/a n/a 3 Sep 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
50
13.54 269.28% 3 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 1
n/a n/a 7 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5
1.11 350.45% 4 Aug 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 9
1 800% 1 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
33 21
n/a n/a 3 May 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Neutral
1
n/a n/a 3 Jan 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1200 80
n/a n/a 2 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5 2
n/a n/a 2 May 6, 2022